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Parkinson disease is a progressive, neurodegenerative disease with an 
increasing incidence of age. It is thought that genetic factors in etiology may 
be the underlying cause together with environmental factors. Sporadic cases 
are seen in 85 %, familial forms in 10-15 %, and single gene inheritance in 5 %. 
In this article, we present a patient with early-onset Parkinson disease who 
had family history but negative genetic analyses. Genetic mutations of 
autosomal recessive early-onset parkinsonism are more frequently evaluated 
in clinical practice and are directed to be analyzed more frequently in a 
selected group of patients. 
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Parkinson Hastalığı insidansı yaş ile artan ilerleyici, nörodejeneratif bir 
hastalıktır. Etiolojide genetik faktörlerin çevresel faktörlerle birlikte altta yatan 
neden olabileceği düşünülmektedir. Sporadik nedenler % 85 oranında 
görülürken, ailesel formlar % 10-15 tek gen katılımı ise % 5 oranında 
görülmektedir. Bu yazıda, aile hikayesi olan ancak genetik analizleri negatif 
olan erken başlangıçlı parkinson hastasını sunduk. Otozomal resesif erken 
başlangıçlı parkinsonizmin genetik mutasyonları klinik pratikte daha sık 
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A 64-year-old female patient was admitted to hospital with progressive gait 
difficulty and balance problems for 6 months. She had hypertension and 
Parkinson disease for 10 years in her past medical history. She was treated 
with levadopa 125mg 3x1. But she feeled worsen end of the dose for 1 year. 
She had decreased facial expression, bradykinesia, mild extremity rigor, but 
no tremor ve rigidty. Myerson, glabellar tap and bilateral palmomental 
reflexes are positive.  





Her gait had decreased step lenght with decreased speed. The patient’s parent 
were not consanguineous. She had 2 sisters and 3 brothers, A 44-year-old 
brother who had Parkinson disease. Also her 75-year-old uncle was diagnosed 
with Parkinson disease and 3 aunts had demantia. The patient was 
hospitalized for regulation for medical theraphy. Brain MRI showed widening 
of bilateral cerebral hemisferes due to atrophy. (figure 1) Result of 
standartized mini mental state examination test was 18/30. Analysis of the 
PARK2, PARK 6, PARK 7, PARK 9 mutation by DNA were negative. Rasajilin 1 
mg and levadopa HBS form added to the medical theraphy. Donepezil 10 mg 
and memantine 20 mg were started for dementia, fluoxetine 20 mg and 
quetiapine 100 mg for anxiety and sleep disorder. After the new medical 
medicaton, the patient had better ability to move, gait and balace. 
Psyhchiatric and sleep disorders were benefit from medical theraphy, too. 
 
 





The majority of patients who get Parkinson disease are over the age of 60. 
When  a patient who is 21-50 old receives a diagnosis with Parkinson disease, 
it is defined as early onset Parkinson disease. Our patient had diagnosed with 
Parkinson disease at the age of 54. We thought that the symptoms of the 
patient started earlier. Since the patient had a severe familial history, the 
patient was considered an early-onset Parkinson disease. Autosomal 






The autosomal recessive form was found to be responsible for PARK2-type 
PARKIN gene, PARK6 for PINK1 gene, PARK7 for DJ-1, and PARK9 for ATP13A2 
gene (1,2,3). When molecular pathology occurs, incorrectly synthesized and 
damaged proteins reveal the phenotypeof early-onset Parkinson disease.  
PARK2 had wide phenotypic features. Also late onset, tremor dominancy, 
fluctuations during the day, early dyskinesia due to levodopa with dystonia 
being rare. So it is difficult to differ the patients with PARKIN from sporadic 
cases (2). Our patient who had not PARKIN gene mutation, had not tremor 
dominancy and early dyskinesia but had wearing off. 
PINK1 mutation with Parkinson patients is characterized by early-onset, 
dystonia and/or psychosis, slowly progression.  Recent study showed that 
PARKIN and PINK1 positive cases had learning, memory abnormalities and 
weaking of circadian rythms (4).  Our patient had slowly progression, memory 
abnormalities. We had not detected PINK1 mutation. 
Mutations in the DJ-1 gene have been reported to be rare from autosomal 
recessive parkinsonism patterns (3). Early-onset, symmetrical involvement, 
slowly progression, levodopa responsive form are seen in DJ-1 positive cases 
(5). Our patient had symmetrical involvement, slowly progression but no DJ-1 
mutation. 
Clinical characteristics of patients with PD-associated ATP13A2 mutations 
were varied. Respective frequency of features: rigidity, bradykinesia, postural 
instability, supranuclear upgaze paresis, cognitive impairment, dystonia, 
resting tremor, hallucination, and myoclonus (6). Different studies in several 
countries with ATP13A2 mutations were detected early-onset (6). Our patient 
had no ATP13A2 mutation. 
As pathogenesis is identified with genes and proteins associated with 
Parkinson, new treatment options can occur (7). Genetic mutations of 
autosomal recessive early-onset parkinsonism are more frequently evaluated 
in clinical practice and are directed to be analyzed more frequently in a 
selected group of patients. 
 
Conflict of interest 




1.Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. 
Mutations in the DJ-1 gene associated with autosomal recessive early-onset 
parkinsonism. Science 2003;299:256-9.  
2.Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, 
et al. Hereditary early-onset Parkinson's disease caused by mutations in PI K1. 
Science 2004;304:1158-60.  
3.Hedrich K, Djarmati A, Schäfer N, Hering R, Wellenbrock C, Weiss PH, et al. 
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in 
early-onset Parkinson disease. Neurology 2004;62:389-94.  
4.Julienne H, Buhl E, Leslie DS, Hodge JJL. Drosophila PINK1 and parkin loss-of-
function mutants display a range of non-motor Parkinson's disease 
phenotypes. Neurobiol Dis. 2017;104:15-23.  
5.Ibáñez P, De Michele G, Bonifati V, Lohmann E, Thobois S, Pollak P, et al; 
French Parkinson's Disease Genetics Study Group. Screening for DJ-1 
mutations in early onset autosomal recessive parkinsonism. Neurology 
2003;61:1429-31.  
6. Yang X, Xu Y. Mutations in the ATP13A2 gene and Parkinsonism: 
apreliminary review. Biomed Res Int. 2014;371256. 
7. Xie W, Wan Wan O, Chung KKK. New insights into the role of mitochondrial 
dysfunction and protein aggregation in Parkinson’s disease. Biochimica et 





Özözen Ayas et al. 
AR PD with early-onset 194 
GMJ 
2019; 30: 193-194 
